Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Berkeley Lights Sued by AbCellera on Antibody Test Patents

July 10, 2020, 4:47 PM

AbCellera Biologics, which is testing antibodies against Covid-19, claims rival Berkeley Lights is using its patented inventions without permission, according to a complaint filed Thursday in federal court in Wilmington, Delaware.

  • The eight patents in the case relate to ways to analyze cells to identify antibodies that can be used to prevent and treat diseases
  • AbCellera said its technology was used to discover the first antibody against Covid-19
    • Eli Lilly is working with closely held AbCellera in the development of so-called “neutralizing” antibodies that are tailored to mimic immune responses to the virus
  • Berkeley Light’s Beacon Optofluidic System, used ...